Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

Clinical trial NCT02300532 · COMPLETED

Trial details

NCT number: NCT02300532
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Malignant Glioma

Start date: 2013-01-10
Primary completion: 2014-07-10
Enrollment: 561

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.